Correction to: Safety profile of brentuximab vedotin in Japanese patients with relapsed/refractory Hodgkin lymphoma or systemic anaplastic large cell lymphoma: a post-marketing surveillance study

Int J Hematol. 2021 Feb 18. doi: 10.1007/s12185-021-03091-0. Online ahead of print.NO ABSTRACTPMID:33604778 | DOI:10.1007/s12185-021-03091-0

Source: International Journal of Hematology - February 19, 2021 Category: Hematology Authors: Koji Izutsu Michinori Ogura Kensei Tobinai Kiyohiko Hatake Shigeru Sakamoto Masanori Nishimura Miyako Hoshino Source Type: research